About the Authors

Lucien Rufener

Affiliations Novartis Centre de Recherche Santé Animale, St. Aubin, Switzerland, Institute of Parasitology, Macdonald College, McGill University, Ste Anne de Bellevue, Quebec, Canada

Nicola Bedoni

Affiliation Department of Biology, University of Fribourg, Fribourg, Switzerland

Roland Baur

Affiliation Institute for Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland

Samantha Rey

Affiliation Department of Biology, University of Fribourg, Fribourg, Switzerland

Dominique A. Glauser

Affiliation Department of Biology, University of Fribourg, Fribourg, Switzerland

Jacques Bouvier

Affiliation Novartis Centre de Recherche Santé Animale, St. Aubin, Switzerland

Robin Beech

Affiliation Institute of Parasitology, Macdonald College, McGill University, Ste Anne de Bellevue, Quebec, Canada

Erwin Sigel

Affiliation Institute for Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland

Alessandro Puoti

alessandro.puoti@unifr.ch

Affiliation Department of Biology, University of Fribourg, Fribourg, Switzerland

Competing Interests

I have read the journal's policy and have the following conflicts: LR and JB authors are currently under the employment of Novartis Animal Health, which provided funds and equipment to conduct part of the studies and where they receive salary, benefits and stock. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials. Monepantel has been developed at Novartis Animal Health. The use of AADs for veterinary purposes is patented (WO2002049641).

Author Contributions

Conceived and designed the experiments: LR NB RBa SR ES DAG RBe JB AP. Performed the experiments: LR NB RBa SR DAG AP. Analyzed the data: LR NB SR RBa ES RBe DAG AP. Contributed reagents/materials/analysis tools: LR JB AP. Wrote the paper: LR ES AP.